SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 79 filers reported holding SERES THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93 | -49.7% | 39,105 | +1.3% | 0.00% | – |
| Q2 2023 | $185 | 0.0% | 38,590 | +18.5% | 0.00% | – |
| Q1 2023 | $185 | -32.7% | 32,570 | -33.6% | 0.00% | – |
| Q4 2022 | $275 | -99.9% | 49,070 | -0.1% | 0.00% | – |
| Q3 2022 | $315,000 | +87.5% | 49,106 | +0.2% | 0.00% | – |
| Q2 2022 | $168,000 | -51.9% | 48,993 | -0.2% | 0.00% | – |
| Q1 2022 | $349,000 | -15.9% | 49,076 | -1.6% | 0.00% | – |
| Q4 2021 | $415,000 | +55.4% | 49,856 | +29.8% | 0.00% | – |
| Q3 2021 | $267,000 | -81.4% | 38,407 | -36.0% | 0.00% | -100.0% |
| Q2 2021 | $1,432,000 | +35.6% | 60,047 | +17.1% | 0.00% | 0.0% |
| Q1 2021 | $1,056,000 | -17.6% | 51,300 | -1.9% | 0.00% | 0.0% |
| Q4 2020 | $1,281,000 | +6.9% | 52,300 | +23.6% | 0.00% | 0.0% |
| Q3 2020 | $1,198,000 | +524.0% | 42,300 | +5.0% | 0.00% | – |
| Q2 2020 | $192,000 | +178.3% | 40,300 | +108.8% | 0.00% | – |
| Q1 2020 | $69,000 | +3.0% | 19,300 | 0.0% | 0.00% | – |
| Q4 2019 | $67,000 | -13.0% | 19,300 | 0.0% | 0.00% | – |
| Q3 2019 | $77,000 | +24.2% | 19,300 | 0.0% | 0.00% | – |
| Q2 2019 | $62,000 | -53.4% | 19,300 | 0.0% | 0.00% | – |
| Q1 2019 | $133,000 | +52.9% | 19,300 | 0.0% | 0.00% | – |
| Q4 2018 | $87,000 | -40.4% | 19,300 | 0.0% | 0.00% | – |
| Q3 2018 | $146,000 | -12.0% | 19,300 | 0.0% | 0.00% | – |
| Q2 2018 | $166,000 | +16.9% | 19,300 | 0.0% | 0.00% | – |
| Q1 2018 | $142,000 | -39.8% | 19,300 | -17.2% | 0.00% | – |
| Q4 2017 | $236,000 | -36.9% | 23,300 | 0.0% | 0.00% | – |
| Q3 2017 | $374,000 | +42.2% | 23,300 | 0.0% | 0.00% | – |
| Q2 2017 | $263,000 | +59.4% | 23,300 | +59.6% | 0.00% | – |
| Q1 2017 | $165,000 | +13.8% | 14,601 | +0.0% | 0.00% | – |
| Q4 2016 | $145,000 | -19.0% | 14,600 | 0.0% | 0.00% | – |
| Q3 2016 | $179,000 | -30.9% | 14,600 | +64.0% | 0.00% | – |
| Q2 2016 | $259,000 | +9.7% | 8,900 | 0.0% | 0.00% | – |
| Q1 2016 | $236,000 | -1.3% | 8,900 | +30.9% | 0.00% | – |
| Q4 2015 | $239,000 | – | 6,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $143,316,000 | 50.54% |
| ARK Investment Management | 765,191 | $8,647,000 | 1.68% |
| Rock Springs Capital Management LP | 220,000 | $2,486,000 | 0.13% |
| Artal Group S.A. | 600,000 | $6,780,000 | 0.12% |
| Virtus ETF Advisers LLC | 29,324 | $331,000 | 0.05% |
| FEDERATED HERMES, INC. | 748,568 | $8,459,000 | 0.02% |
| PDT Partners, LLC | 25,500 | $288,000 | 0.01% |
| Baker Brothers Advisors | 125,000 | $1,413,000 | 0.01% |
| D. E. Shaw & Co., Inc. | 527,261 | $5,958,000 | 0.01% |
| FMR LLC | 6,056,294 | $68,436,000 | 0.01% |